ID   911
AC   CVCL_1K15
SY   HER;911; HER911; Human Embryonic Retinoblasts 911
DR   Wikidata; Q54605659
RX   Patent=US6602706;
RX   PubMed=8788172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 95062101.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5 [Note=E1].
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Cell type: Retinoblast; CL=CL_4023129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G704 ! PER.C6
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 15
RX   Patent=US6602706;
RA   Fallaux F.J., Hoeben R.C., van der Eb A.J., Bout A., Valerio D.;
RT   "Packaging systems for human recombinant adenovirus to be used in gene
RT   therapy.";
RL   Patent number US6602706, 05-Aug-2003.
RX   PubMed=8788172; DOI=10.1089/hum.1996.7.2-215;
RA   Fallaux F.J., Kranenburg O.W., Cramer S.J., Houweling A.,
RA   van Ormondt H., Hoeben R.C., van der Eb A.J.;
RT   "Characterization of 911: a new helper cell line for the titration and
RT   propagation of early region 1-deleted adenoviral vectors.";
RL   Hum. Gene Ther. 7:215-222(1996).